National Institute for Health and Clinical Excellence (NICE)
Treat life-threatening sepsis within the hour, says NICE
NICE is urging hospital staff to treat people with life-threatening sepsis symptoms within one hour.
In a new draft quality standard, NICE says people showing signs of sepsis must be checked carefully. Once someone is classed as high-risk they should be seen by senior staff and given the right treatment within an hour.
Professor Gillian Leng, NICE deputy chief executive, said: “Severe symptoms can develop in sepsis very quickly. If high-risk patients are not identified and treated promptly, people can be left with debilitating problems. In the worst cases, they may die.
“This quality standard highlights priorities in the continued fight to improve sepsis care. We know from recent case reviews that there are inconsistencies in how people’s symptoms are assessed in different settings. More can be done to provide rapid treatment.”
The quality standard highlight areas from NICE’s 2016 sepsis guideline that will help health professionals improve care for those who are at risk of becoming seriously ill.
It stresses that staff in any setting, from GPs to paramedics, should check people for specific signs that will show if their symptoms are life-threatening. This includes taking their temperature or heart rate, or checking for rashes and skin discolouration.
Anyone found to be high-risk should be seen by senior hospital staff immediately. This review would be carried out by an available doctor or nurse who is authorised to prescribe antibiotics.
Dr Ron Daniels BEM, Chief Executive of the UK Sepsis Trust, comments: “An emphasis on timely treatment and diagnosis is crucial if we are to improve outcomes for people with sepsis, and this quality standard could be a hugely impactful reinforcement of the recent guideline recommendation that sepsis is treated with same urgency as heart attacks.”
NICE says that high-risk sepsis patients should get antibiotics and IV fluid treatment within the hour. If it will take more than an hour to get someone to hospital, GPs or ambulance staff can also administer antibiotics.
Prompt treatment means people are more likely to survive and it reduces the risk of further problems like heart failure or limb amputation.
The 2015 report from the National Confidential Enquiry into Patient Outcome and Death found that 40% of people admitted to A&E with sepsis did not have a timely review by a senior clinician. It also reported avoidable delays in administering antibiotics in more than a quarter (29%) of cases and inconsistencies in early use of intravenous (IV) fluid.
Health Secretary Jeremy Hunt said: “Every death from sepsis is a tragedy, yet too often the warning signs are missed - we need to get far better at spotting sepsis across the NHS and this advice shows how vital it is for clinicians to treat life-threatening symptoms as soon as possible.
“Our relentless drive to raise awareness of this deadly condition, as well as the tireless efforts of campaigners and families who have lost loved ones, has seen a million leaflets and posters already distributed to GP clinics, hospitals and other public places - helping raise awareness to fight against this devastating condition.”
A recent study from the York Health Economics Consortium suggests that 260,000 people in the UK develop sepsis every year. And the UK Sepsis Trust estimates that sepsis kills around 44,000 people per year.
Not everyone with sepsis will be at risk of getting seriously ill. NICE says that people who are classed as low-risk should get information on what to do if they continue to feel unwell and how to get further medical help.
NICE is asking for views on the draft quality standard. It is out for public consultation until Friday 7 April 2017.
Latest News from
National Institute for Health and Clinical Excellence (NICE)
Test people with womb cancer for inherited genetic condition, NICE says in new guidance29/10/2020 11:15:00
Research led by Professor Emma Crosbie, with Professor Gareth Evans and Dr Neil Ryan from The University of Manchester and Manchester University NHS Foundation Trust, showed the benefits of different testing strategies for Lynch syndrome in womb cancer cases in increasing diagnosis of the condition.
Inside NICE: My experience of the scholarship programme26/10/2020 11:15:00
Howard Ryland, National Institute of Health Research (NIHR) Doctoral Research Fellow at the Department of Psychiatry at the University of Oxford, discusses his experience as a NICE scholar.
NICE gears up to support World Evidence-based Healthcare Day16/10/2020 15:43:00
Inaugural World Evidence-based Healthcare (EBHC) Day takes place on Tuesday 20 October 2020.
NICE draft guidance recommends siponimod for treating secondary progressive multiple sclerosis16/10/2020 14:15:00
NICE yesterday (15 October 2020) issued a draft guidance which now recommends siponimod (also called Mayzent and made by Novartis) for treating secondary progressive multiple sclerosis (MS).
World Evidence-Based Healthcare Day: Using evidence to inform our recommendations15/10/2020 14:38:00
Martin discusses World Evidence-Based Healthcare Day and how NICE uses evidence to inform our recommendations.
Evidence for HTA: Innovative methods for challenging times14/10/2020 12:43:00
Dalia Dawoud, Scientific Adviser at NICE Science, Evidence and Analytics Directorate explains NICE’s role as co-host of HTAi 2021 in the UK.
NICE non-executive director Elaine Inglesby-Burke CBE awarded Damehood for services to nursing13/10/2020 13:33:00
Elaine has been honoured in the Queen’s birthday honours list to recognise her commitment to the profession.
NICE proposes simplifying how medicines and medical devices are selected for evaluation.12/10/2020 16:15:00
As part of the work underway to review the methods and processes NICE uses to develop guidance on medicines, medical devices and diagnostics, NICE has launched a public consultation on proposals for changing how it selects the topics it will develop guidance on.
NICE & SIGN announce latest rapid Covid-19 guideline will address Long Covid06/10/2020 16:15:00
NICE and the Scottish Intercollegiate Guidelines Network (SIGN) yesterday (5 October 2020) announced they will work with the Royal College of General Practitioners (RCGP) to develop a guideline on persistent effects of Covid-19 (Long Covid) on patients.